Gene · 10481
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Germline ATM Mutations Detected by Somatic DNA Sequencing in Lethal Prostate Cancer. | Eur Urol Open Sci | 2023 | 37284046 | PubTator, text mining | PubMed |
| Development and nationwide validation of kidney graft injury markers using urinary exosomes and microvesicles (complete English translation of the Japanese version). | BMC Nephrol | 2023 | 37280521 | PubTator, text mining | PubMed |
| MCM10: An effective treatment target and a prognostic biomarker in patients with uterine corpus endometrial carcinoma. | J Cell Mol Med | 2023 | 37246638 | PubTator, text mining | PubMed |
| Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers. | Clin Epigenetics | 2023 | 37245006 | PubTator, text mining | PubMed |
| Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate Cancer. | Int J Mol Sci | 2023 | 37240349 | PubTator, text mining | PubMed |
| Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool. | Genes (Basel) | 2023 | 37239385 | PubTator, text mining | PubMed |
| Hereditary Breast Cancer in Romania-Molecular Particularities and Genetic Counseling Challenges in an Eastern European Country. | Biomedicines | 2023 | 37239058 | PubTator, text mining | PubMed |
| Recent advances in understanding DNA methylation of prostate cancer. | Front Oncol | 2023 | 37234978 | PubTator, text mining | PubMed |
| Clinicopathological Characteristics and Mutational Landscape of APC, HOXB13, and KRAS among Rwandan Patients with Colorectal Cancer. | Curr Issues Mol Biol | 2023 | 37232746 | PubTator, text mining | PubMed |
| Establishment, characterization, and drug screening of low-passage patient individual non-small cell lung cancer in vitro models including the rare pleomorphic subentity. | Front Oncol | 2023 | 37228492 | PubTator, text mining | PubMed |
| An Update on Genetic Predisposition for Prostate Cancer: Perspectives and Prospects. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37224054 | PubTator, text mining | PubMed |
| Novel biomarkers for early detection of gastric cancer. | World J Gastroenterol | 2023 | 37213407 | PubTator, text mining | PubMed |
| The Role of Biomarkers in Guiding Clinical Decision-Making in Oncology. | J Adv Pract Oncol | 2023 | 37206905 | PubTator, text mining | PubMed |
| HMBOX1, a member of the homeobox family: current research progress. | Cent Eur J Immunol | 2023 | 37206587 | PubTator, text mining | PubMed |
| Mechanisms of N6‑methyladenosine modification in tumor development and potential therapeutic strategies (Review). | Int J Oncol | 2023 | 37203412 | PubTator, text mining | PubMed |
| Epigenetic Modifications in Prostate Cancer Metastasis and Microenvironment. | Cancers (Basel) | 2023 | 37190171 | PubTator, text mining | PubMed |
| Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond. | Curr Oncol | 2023 | 37185436 | PubTator, text mining | PubMed |
| The Transcriptomic Profiles of ESR1 and MMP3 Stratify the Risk of Biochemical Recurrence in Primary Prostate Cancer beyond Clinical Features. | Int J Mol Sci | 2023 | 37176106 | PubTator, text mining | PubMed |
| Risk Effects of rs1799945 Polymorphism of the HFE Gene and Intergenic Interactions of GWAS-Significant Loci for Arterial Hypertension in the Caucasian Population of Central Russia. | Int J Mol Sci | 2023 | 37176017 | PubTator, text mining | PubMed |
| Roles of the PARP Inhibitor in BRCA1 and BRCA2 Pathogenic Mutated Metastatic Prostate Cancer: Direct Functions and Modification of the Tumor Microenvironment. | Cancers (Basel) | 2023 | 37174127 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10481/papers?page=14